Literature DB >> 28728176

The Epidemiology of Retinopathy of Prematurity in the United States.

Cassie A Ludwig, Tiffany A Chen, Tina Hernandez-Boussard, Andrew A Moshfeghi, Darius M Moshfeghi.   

Abstract

BACKGROUND AND
OBJECTIVE: Retinopathy of prematurity (ROP) is a leading cause of blindness in premature and low birth weight infants. Here, the authors examine the incidence of ROP in the United States and evaluate risk factors associated with ROP development. PATIENTS AND METHODS: The National Healthcare Cost and Utilization Project Kids' Inpatient Database was queried for all newborns with and without ROP. Adjusted odds ratios were constructed for predictors of ROP using multivariate logistic regression modeling.
RESULTS: The incidence of ROP increased from 14.70% in 2000 to 19.88% in 2012. Multivariate regression analysis indicated that female gender, birth weight, and gestational age predicted ROP. The frequency of ROP was 2.40% in newborns weighing more than 2,500 grams (g) and 30.22% in newborns with a birth weight between 750 g and 999 g.
CONCLUSIONS: The authors' report examines a nationwide cohort of ROP infants and reveals an increase in the incidence of ROP from 2000 to 2012. This trend is inversely related to a simultaneous decline in newborn mortality. [ Ophthalmic Surg Lasers Imaging Retina . 2017;48:553-562.]. Copyright 2017, SLACK Incorporated.

Entities:  

Mesh:

Year:  2017        PMID: 28728176     DOI: 10.3928/23258160-20170630-06

Source DB:  PubMed          Journal:  Ophthalmic Surg Lasers Imaging Retina        ISSN: 2325-8160            Impact factor:   1.300


  29 in total

1.  The association between high levels of luteinizing hormone and proliferative retinopathy of prematurity in female preterm infants.

Authors:  Tammy Z Movsas; Ira H Gewolb; Nigel Paneth; Qing Lu; Arivalagan Muthusamy
Journal:  J AAPOS       Date:  2020-06-06       Impact factor: 1.220

2.  Zone of retinal vascularization and refractive error in premature eyes with and without spontaneously regressed retinopathy of prematurity.

Authors:  Mark S Dikopf; Lindsay A Machen; Joelle A Hallak; Felix Y Chau; Iris S Kassem
Journal:  J AAPOS       Date:  2019-06-20       Impact factor: 1.220

3.  Retinopathy of prematurity occurrence and evaluation of screening policy in a large tertiary Greek cohort.

Authors:  Asimina Mataftsi; Stella Moutzouri; Paraskevi Karagianni; Nikolaos Ziakas; Vasiliki Soubasi; Periklis Brazitikos; Anna-Bettina Haidich
Journal:  Int Ophthalmol       Date:  2019-10-22       Impact factor: 2.031

4.  Effect of anti-VEGF treatment on retinopathy of prematurity in Zone II Stage 3.

Authors:  Xiu-Mei Yang; Yue-Xiang Zhao; Zong-Hua Wang; Lu Liu
Journal:  Int J Ophthalmol       Date:  2018-04-18       Impact factor: 1.779

5.  Efficacy evaluation of intravitreal ranibizumab therapy for three types of retinopathy of prematurity.

Authors:  Qiong Zou; Yan-Qiong Zhu; Feng-Jun Zhang; Qiu-Ping Liu
Journal:  Int J Ophthalmol       Date:  2022-05-18       Impact factor: 1.779

6.  Efficacy of water-based vitamin E solution versus placebo in the prevention of retinopathy of prematurity in very low birth weight infants: A randomized clinical trial.

Authors:  Silvia Romero-Maldonado; Araceli Montoya-Estrada; Enrique Reyes-Muñoz; Alberto Martín Guzmán-Grenfell; Yessica Dorin Torres-Ramos; Mario David Sánchez-Mendez; Maricruz Tolentino-Dolores; Manuel Bernardo Salgado-Valladares; Aurora Belmont-Gómez; Nayelli Najéra; Guillermo Ceballos; Jorge Arturo Cardona-Pérez; Juan José Hicks; Javier Mancilla-Ramírez
Journal:  Medicine (Baltimore)       Date:  2021-08-06       Impact factor: 1.817

7.  A review of treatment for retinopathy of prematurity.

Authors:  Eric D Hansen; M Elizabeth Hartnett
Journal:  Expert Rev Ophthalmol       Date:  2019-03-29

8.  Foveal structure changes in infants treated with anti-VEGF therapy or laser therapy guided by optical coherence tomography angiography for retinopathy of prematurity.

Authors:  Xun Deng; Yong Cheng; Xue-Mei Zhu; Dan-Dan Linghu; Hua Xu; Jian-Hong Liang
Journal:  Int J Ophthalmol       Date:  2022-01-18       Impact factor: 1.779

9.  Retinopathy of Prematurity: Advances in the Screening and Treatment of Retinopathy of Prematurity Using a Single Center Approach.

Authors:  Audina M Berrocal; Kenneth C Fan; Hasenin Al-Khersan; Catherin I Negron; Timothy Murray
Journal:  Am J Ophthalmol       Date:  2021-07-21       Impact factor: 5.258

10.  Incidence and Risk Factors Associated with Retinopathy of Prematurity in Peru.

Authors:  Carmen Sarita Carranza-Mendizabal; Mariela Diaz-Manrique; Percy G Ruiz Mamani; Michael White; Salomon Huancahuire-Vega
Journal:  Clin Ophthalmol       Date:  2021-05-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.